Short-Term Debt to Capital: CooperCompanies (COO)

coopercos.com - graphic logo of issuer COO

The Cooper Companies (COO) strategy under Alan White ensures steady revenue growth through the effective merger of assets. The change in short-term liabilities relative to equity confirms the resilience of this model, where 0.05 characterizes this valuation parameter. Growth potential relies on the transition to silicone hydrogel and pricing power. Meanwhile, aggressive expansion in the women's health segment is funded by profits from lens sales.

COO - The Cooper Companies, Inc. Short-Term Debt to Capital Coefficient over the range 07/04/2022 - 10/31/2026
Signature product of coopercos.com

To identify the fundamental leaders of the sector, the analyst evaluates the stability of the liability structure. This ratio compares obligations with a maturity of up to one year against equity to measure the risk of shareholder value dilution. For The Cooper Companies (COO), with its in-house lens production, such a metric confirms the ability to service current debts without compromising capital. The trend of the short-term debt-to-equity ratio reflects the balance between operational autonomy and financial efficiency.

Competitor analysis for The Cooper Companies

Short-Term Debt to Capital BSX|EW - Current Liabilities to Capital|Short-Term Debt to Capital RMD (ResMed Inc.)|PODD - Short-Term Debt to Equity Ratio|Zimmer Biomet Holdings - Short-Term Debt to Capital|Short-Term Debt to Capital Coefficient Invisalign ALGN|GMED: Short-Term Debt to Capital|TransMedics Group, Inc. (TMDX) - Short-Term Debt to Capital|Short-Term Debt to Equity Alphatec Holdings, Inc.|Short-Term Debt to Equity AORT|Short-Term Debt to Capital ENOV|Short-Term Debt to Capital Coefficient Integra LifeSciences Corp|Motiva - Short-Term Debt to Equity Ratio|BBNX (iLet Bionic Pancreas) - Current Liabilities to Equity|IRADIMED CORPORATION - Short-Term Debt to Capital|Current Liabilities to Capital embecta.com|TNDM: Short-Term Debt to Capital|Short-Term Debt to Capital Ratio AXGN|Short-Term Debt to Equity Ratio SIBN|OFIX: Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Bioventus Inc. (BVS)|Short-Term Debt to Equity Ratio orthopediatrics.com KIDS|Short-Term Debt to Capital TMCI (Treace Medical Concepts, Inc.)|Blade Air Mobility (SRTA) - Current Liabilities to Capital|Carlsmed Corp - Short-Term Debt to Capital|RXST (RxSight Ophthalmic) - Short-Term Debt to Capital Ratio|CLPT: Short-Term Debt to Capital|STXS - Short-Term Debt to Capital Coefficient|STIM (Neuronetics) - Short-Term Debt to Capital|Short-Term Debt to Equity Ratio Sight Sciences Inc. (SGHT)|Short-Term Debt to Capital OBIO|Short-Term Debt to Capital anikatherapeutics.com (ANIK)|Short-Term Debt to Equity InspireMD, Inc. NSPR|Jin Medical International Ltd. - Short-Term Debt to Equity|VANI: Short-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital XTNT (Xtant Medical Holdings)|NMTC: Short-Term Debt to Capital|Current Liabilities to Capital Modular Medical, Inc. (MODD)|Short-Term Debt to Equity Myomo, Inc.|COCH - Short-Term Indebtedness to Equity|Short-Term Debt to Equity Ratio VVOS (Vivos Therapeutics, Inc.)|Short-Term Debt to Capital enVVeno Medical Corporation (NVNO)|Short-Term Debt to Capital SINT (Sintx Technologies, Inc.)|Short-Term Debt to Capital Coefficient Tenon Medical Inc (TNON)|LFWD - Short-Term Debt to Equity|Current Liabilities to Equity AMIX|INVO Fertility (IVF) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Bone Biologics Corp.|AXNX (Axonics Modulation Technologies) - Short-Term Debt to Capital|Current Liabilities to Capital Biolase Inc. BIOL|Short-Term Debt to Equity Dynatronics Corporation (DYNT)|paragon28.com - Short-Term Debt to Capital Ratio|INVO Bioscience - Short-Term Debt to Equity Ratio